• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发新型氟比洛芬固体自微乳给药系统,使用明胶作为固体载体。

Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.

机构信息

College of Pharmacy, Hanyang University, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan 426-791, South Korea.

出版信息

J Microencapsul. 2012;29(4):323-30. doi: 10.3109/02652048.2011.651497. Epub 2012 Jan 10.

DOI:10.3109/02652048.2011.651497
PMID:22233141
Abstract

To develop a novel flurbiprofen-loaded solid self-microemulsifying drug delivery system (solid SMEDDS) with improved oral bioavailability using gelatin as a solid carrier, the solid SMEDDS formulation was prepared by spray-drying the solutions containing liquid SMEDDS and gelatin. The liquid SMEDDS, composed of Labrafil M 1944 CS/Labrasol/Transcutol HP (12.5/80/7.5%) with 2% w/v flurbiprofen, gave a z-average diameter of about 100 nm. The flurbiprofen-loaded solid SMEDDS formulation gave a larger emulsion droplet size compared to liquid SMEDDS. Unlike conventional solid SMEDDS, it produced a kind of microcapsule in which liquid SMEDDS was not absorbed onto the surfaces of carrier but formed together with carrier in it. However, the drug was in an amorphous state in it like conventional solid SMEDDS. It greatly improved the oral bioavailability of flurbiprofen in rats. Thus, gelatin could be used as a carrier in the development of solid SMEDDS with improved oral bioavailability of poorly water-soluble drug.

摘要

为了开发一种新型的负载氟比洛芬的固体自微乳药物传递系统(固体自微乳),以提高口服生物利用度,采用明胶作为固体载体,通过喷雾干燥含有液体自微乳和明胶的溶液来制备固体自微乳制剂。液体自微乳由 Labrafil M 1944 CS/Labrasol/Transcutol HP(12.5/80/7.5%)和 2% w/v 的氟比洛芬组成,粒径约为 100nm。与液体自微乳相比,负载氟比洛芬的固体自微乳制剂的乳滴粒径更大。与传统的固体自微乳不同,它产生了一种微胶囊,其中液体自微乳没有被吸收到载体的表面上,而是与载体一起形成。然而,药物在其中呈无定形状态,与传统的固体自微乳一样。它大大提高了氟比洛芬在大鼠体内的口服生物利用度。因此,明胶可用作固体自微乳的载体,以提高难溶性药物的口服生物利用度。

相似文献

1
Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.开发新型氟比洛芬固体自微乳给药系统,使用明胶作为固体载体。
J Microencapsul. 2012;29(4):323-30. doi: 10.3109/02652048.2011.651497. Epub 2012 Jan 10.
2
Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier.比较亲水和疏水固体载体制备的固体自微乳药物传递系统(固体 SMEDDS)。
Int J Pharm. 2011 Nov 28;420(2):412-8. doi: 10.1016/j.ijpharm.2011.09.007. Epub 2011 Sep 16.
3
Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).固体载体对氟比洛芬固体自微乳给药系统(固体 SNEDDS)中结晶性质、溶出度和生物利用度的影响。
Eur J Pharm Biopharm. 2012 Feb;80(2):289-97. doi: 10.1016/j.ejpb.2011.11.005. Epub 2011 Nov 18.
4
A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.一种通过喷雾干燥制备的新型固体自微乳化制剂,用于提高难溶性药物的口服生物利用度。
Eur J Pharm Biopharm. 2008 Oct;70(2):439-44. doi: 10.1016/j.ejpb.2008.05.001. Epub 2008 May 17.
5
Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.固体自微乳药物传递系统增强非诺贝特的口服生物利用度。
Drug Dev Ind Pharm. 2013 Sep;39(9):1431-8. doi: 10.3109/03639045.2012.719903. Epub 2012 Oct 9.
6
Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.难溶性药物氯诺昔康口服自乳化系统的制备及药代动力学评价
Drug Deliv. 2015;22(4):487-98. doi: 10.3109/10717544.2014.885615. Epub 2014 Feb 13.
7
Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement.用于提高口服生物利用度的叶下珠素自微乳化药物递送系统的研发。
Drug Dev Ind Pharm. 2015 Feb;41(2):207-17. doi: 10.3109/03639045.2013.858732. Epub 2013 Nov 18.
8
Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.姜黄素自微乳制剂和微丸制剂的研制与评价及其在大鼠体内的吸收研究。
Eur J Pharm Biopharm. 2010 Nov;76(3):475-85. doi: 10.1016/j.ejpb.2010.07.011. Epub 2010 Jul 24.
9
Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.冬凌草甲素自微乳化药物传递系统的制备与评价
Int J Pharm. 2008 May 1;355(1-2):269-76. doi: 10.1016/j.ijpharm.2007.12.026. Epub 2007 Dec 27.
10
Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.开发一种用于提高萘普生溶解度的固体自微乳化药物递送系统(SMEDDS)。
Drug Dev Ind Pharm. 2015;41(9):1548-57. doi: 10.3109/03639045.2014.971031. Epub 2015 Jul 14.

引用本文的文献

1
Formulation and In Vivo Evaluation of a Solid Self-Emulsifying Drug Delivery System Using Oily Liquid Tocotrienols as Model Active Substance.以油性液态生育三烯酚为模型活性物质的固体自乳化药物递送系统的制剂及体内评价
Pharmaceutics. 2021 Oct 25;13(11):1777. doi: 10.3390/pharmaceutics13111777.
2
The complete chloroplast genome and characteristics analysis of Musa basjoo Siebold.芭蕉(Musa basjoo Siebold.)的完整叶绿体基因组及其特征分析。
Mol Biol Rep. 2021 Nov;48(11):7113-7125. doi: 10.1007/s11033-021-06702-5. Epub 2021 Sep 19.
3
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.
过饱和自乳化药物递送系统的现状
Pharmaceutics. 2020 Apr 16;12(4):365. doi: 10.3390/pharmaceutics12040365.
4
Alginate-Based Composite Sponges as Gastroretentive Carriers for Curcumin-Loaded Self-Microemulsifying Drug Delivery Systems.基于海藻酸盐的复合海绵作为载姜黄素自微乳化药物递送系统的胃滞留载体
Sci Pharm. 2017 Mar 15;85(1):11. doi: 10.3390/scipharm85010011.
5
Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib.用于提高厄洛替尼口服生物利用度的固体自乳化制剂的研发。
AAPS PharmSciTech. 2016 Apr;17(2):466-73. doi: 10.1208/s12249-015-0370-5. Epub 2015 Aug 4.
6
Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe's design for improvement of oral bioavailability of nelfinavir mesylate.应用谢弗设计开发和优化固体自微乳药物传递系统(S-SNEDDS)以提高甲磺酸奈非那韦的口服生物利用度。
Drug Deliv Transl Res. 2014 Apr;4(2):171-86. doi: 10.1007/s13346-014-0191-1.
7
Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.将基于脂质的口服药物传递系统转化为固体剂型:固体载体、理化性质和生物药剂学性能概述。
Pharm Res. 2013 Dec;30(12):2993-3017. doi: 10.1007/s11095-013-1107-3. Epub 2013 Jun 18.
8
In vitro digestion of the self-emulsifying lipid excipient Labrasol(®) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate.自乳化脂质辅料 Labrasol(®)在胃肠脂肪酶中的体外消化及其胶体结构对脂肪酶解速率的影响。
Pharm Res. 2013 Dec;30(12):3077-87. doi: 10.1007/s11095-013-1053-0. Epub 2013 May 2.